`Filed: May 9, 2017
`
`Filed on behalf of: Sumitomo Dainippon Pharma Co., Ltd.
`
`By: Preston K. Ratliff II (PH-Par-Sunovion-IPR@paulhastings.com)
`
`Joseph M. O’Malley, Jr. (PH-Par-Sunovion-IPR@paulhastings.com)
`
`Naveen Modi (PH-Par-Sunovion-IPR@paulhastings.com)
`
`Michael A. Stramiello, Ph.D. (PH-Par-Sunovion-IPR@paulhastings.com)
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner
`
`v.
`
`SUMITOMO DAINIPPON PHARMA CO., LTD.,
`Patent Owner
`
`
`
`
`Case IPR2017-01292
`U.S. Patent No. 9,555,027
`
`
`
`POWER OF ATTORNEY FOR PATENT OWNER
`SUMITOMO DAINIPPON PHARMA CO., LTD.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2017-01292
`
`US. Patent 9,555,027
`
`Pursuant to 37 C.F.R. § 42.10(b), Sumitomo Dainippon Pharma Co., Ltd.
`
`appoints the practitioners associated with Paul Hastings LLP, Customer
`
`Number 36,138, including Preston K. Ratliff II, Naveen Modi, and Michael A.
`
`Strarniello, Ph.D., as well as Joseph M. O’Malley, Jr., who will be filing a motion
`
`for pro hac vice, as its attorneys to transact all business in the United States Patent
`
`& Trademark Office associated with any interpartes review of US. Patent
`
`No. 9,555,027.
`
`Date: May 3, 2017
`
`By:
`
`K
`
`_W
`
`Name: Tetsuya Uyarna
`Title: Senior Director, Legal Affairs
`Sumitomo Dainippon Pharma Co., Ltd.
`
`
`
`Case IPR2017-01292
`U.S. Patent 9,555,027
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on May 9, 2017, a copy of the foregoing Power of
`
`Attorney for Patent Owner was served by e-mail on the following counsel of
`
`record for Petitioner:
`
`Daniel G. Brown (daniel.brown@lw.com)
`Jonathan M. Strang (jonathan.strang@lw.com)
`
`Respectfully submitted,
`
`/Preston K. Ratliff II/
`Preston K. Ratliff II, Reg. No. 43,034
`Joseph M. O’Malley, Jr. (pro hac vice pending)
`Naveen Modi, Reg. No. 46,224
`Michael A. Stramiello, Ph.D., Reg. No. 67,195
`
`Counsel for Patent Owner
`
`
`
`
`
`
`Date: May 9, 2017
`
`
`
`
`
`